• Fasenra: Double Action for EGPA

    EGPA now has a second treatment! Fasenra was approved in the fall of 2024 for EGPA and brings a new take on addressing the issues. Join this livestream to learn about the dual impact: IL-5 unique action and activating natural killer cells. 

  • Decision Tree: Best Practice For Care

    Figuring out how to navigate the complex health care system can be maddening. Join us to learn about a tool that will help you find the care you need and reduce the stress and strain of making decisions each step of the way!

  Subscribe to our newsletter

Get regular updates to your inbox.

This field is for validation purposes and should be left unchanged.